References
Stansfeld AG, Diebold J, Noel H et al (1988) Updated Kiel classification for lymphomas. Lancet 1:292–293 (letter)
Berger F, Felman P, Sonet A et al (1994) Nonfollicular small B-cell lymphomas: a heterogeneous group of patients with distinct clinical features and outcome. Blood 83:2829–2835
Harris NL, Jaffe ES, Stein H et al (1994) A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84: 1361–1392
Harris NL, Bhan AK (1985) B-cell neoplasms of the lymphocytic lymphoplasmacytoid, and plasma cell types: immunohistologic analysis and clinical correlation. Hum Pathol 16:829–837
Foran J, Rohatiner A, Coiffier B et al (1999) Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström’s macroglobulinemia, and mantle-cell lymphoma. J Clin Oncol 17:546–553
Baldini L, Brugiatelli M, Luminari S et al (2003) Treatment of indolent B-cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi. J Clin Oncol 21:1459–1465
Hainsworth JD, Litchy S, Morrissey LH et al (2005) Rituximab plus short-duration chemotherapy as first-line treatment for follicular non- Hodgkin’s lymphoma: a phase II Trial of the Minnie Pearl Cancer Research Network. J Clin Oncol 23:1500–1506
Witzig T, Vukov A, Habermann T et al (2005) Rituximab therapy for patients with newly diagnosed, advanced-stage, follicular grade I non- Hodgkin’s lymphoma: a phase II trial in the North Central Cancer Treatment Group. J Clin Oncol 23:1103–1108
Dimopoulos MA, Alexanian R (1994) Waldenstrom’s macroglobulinemia. Blood 83:1452–1459
Dimopoulos M, Zervas C, Zomas A et al (2002) Treatment of Waldenström’s macroglobulinemia with rituximab. J Clin Oncol 20:2327–2333
Dimopoulos MA, Kyle RA, Anagnostopoulos A et al (2005) Diagnosis and management of Waldenstrom’s macroglobulinemia. J Clin Oncol 23:1564–1577
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blancas López-Barajas, I., Zarcos, I., Gómez, F.J. et al. Plasmacytoid lymphoma treated with rituximab as first-line monotherapy. Clin Transl Oncol 11, 704–706 (2009). https://doi.org/10.1007/s12094-009-0429-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-009-0429-4